Wealthspire Advisors (New York)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Wealthspire Advisors (New York)'s GILD Position: Q1 2026 in Review
Wealthspire Advisors (New York) reduced its Gilead Sciences (GILD) stake by 70% in Q1 2026, selling an estimated $876K and leaving 2,674 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #664.
Wealthspire Advisors (New York) first reported a position in GILD in Q4 2018 and has held it in 17 quarters since. The position peaked at $1.34M in Q1 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Wealthspire Advisors (New York) held 2,674 shares of Gilead Sciences worth $373K as of Q1 2026.
- Wealthspire Advisors (New York) sold 6,255 Gilead Sciences shares in Q1 2026, an estimated $876K.
- Gilead Sciences made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #664 holding.
- Wealthspire Advisors (New York) first reported a position in Gilead Sciences in Q4 2018 and has held it in 17 quarters since.
- Wealthspire Advisors (New York)'s Gilead Sciences position peaked at $1.34M in Q1 2020.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.